176 related articles for article (PubMed ID: 24760484)
1. Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study.
He YT; Ou AH; Yang XB; Chen W; Fu LY; Lu AP; Yan XP; Feng XH; Su L; Song YJ; Zeng SP; Liu W; Qian X; Zhu WH; Lao YR; Xu WH; Wen ZH; He XH; Wang BJ; Chen GX; Xue SQ
Rheumatol Int; 2014 Dec; 34(12):1647-55. PubMed ID: 24760484
[TBL] [Abstract][Full Text] [Related]
2. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
[TBL] [Abstract][Full Text] [Related]
3. Differential effect on symptoms treated with traditional Chinese medicine and western combination therapy in RA patients.
He Y; Lu A; Zha Y; Tsang I
Complement Ther Med; 2008 Aug; 16(4):206-11. PubMed ID: 18638711
[TBL] [Abstract][Full Text] [Related]
4. Correlations between symptoms as assessed in traditional chinese medicine (TCM) and ACR20 efficacy response: a comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western medicine.
He Y; Lu A; Zha Y; Yan X; Song Y; Zeng S; Liu W; Zhu W; Su L; Feng X; Qian X; Lu C
J Clin Rheumatol; 2007 Dec; 13(6):317-21. PubMed ID: 18176139
[TBL] [Abstract][Full Text] [Related]
5. Association between tongue appearance in Traditional Chinese Medicine and effective response in treatment of rheumatoid arthritis.
Jiang M; Zha Q; Lu C; He Y; Lu A
Complement Ther Med; 2011 Jun; 19(3):115-21. PubMed ID: 21641515
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis.
Liu W; Wu YH; Hu SY; Zhong CL; Gao ML; Liu DW; Wang HY; Chen MZ; Song YJ; Yang BZ; Zheng QS; Yao H; Qi XB; Li G
Trials; 2016 Jul; 17():359. PubMed ID: 27465818
[TBL] [Abstract][Full Text] [Related]
7. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Yishen Tongbi decoction versus methotrexate in patients with active rheumatoid arthritis: A double-blind, randomized, controlled, non-inferiority trial.
Xu J; Zhang L; Xu Y; Yu J; Zhao L; Deng H; Li M; Zhang M; Lei X; Hu C; Jiao W; Dai Z; Liu L; Chen G
Phytomedicine; 2023 Apr; 112():154704. PubMed ID: 36796186
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
Gubar' EE; Bochkova AG; Bunchuk NV
Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy.
Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC
Int J Rheum Dis; 2016 Nov; 19(11):1143-1156. PubMed ID: 26259617
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
Braun J; Kästner P; Flaxenberg P; Währisch J; Hanke P; Demary W; von Hinüber U; Rockwitz K; Heitz W; Pichlmeier U; Guimbal-Schmolck C; Brandt A;
Arthritis Rheum; 2008 Jan; 58(1):73-81. PubMed ID: 18163521
[TBL] [Abstract][Full Text] [Related]
12. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
[TBL] [Abstract][Full Text] [Related]
13. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate.
Lee WS; Lee SI; Lee MS; Kim SI; Lee SS; Yoo WH
Korean J Intern Med; 2016 Jul; 31(4):779-87. PubMed ID: 26961485
[TBL] [Abstract][Full Text] [Related]
15. Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis.
He Y; Lu A; Lu C; Zha Y; Yan X; Song Y; Zeng S; Liu W; Zhu W; Su L; Feng X; Qian X; Tsang I
Am J Chin Med; 2008; 36(4):675-83. PubMed ID: 18711765
[TBL] [Abstract][Full Text] [Related]
16. A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.
Hu D; Bao C; Chen S; Gu J; Li Z; Sun L; Han X; Ni L
Rheumatol Int; 2009 Jan; 29(3):297-303. PubMed ID: 18704426
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
[TBL] [Abstract][Full Text] [Related]
18. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.
Emery P; Fleischmann RM; Moreland LW; Hsia EC; Strusberg I; Durez P; Nash P; Amante EJ; Churchill M; Park W; Pons-Estel BA; Doyle MK; Visvanathan S; Xu W; Rahman MU
Arthritis Rheum; 2009 Aug; 60(8):2272-83. PubMed ID: 19644849
[TBL] [Abstract][Full Text] [Related]
19. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
[TBL] [Abstract][Full Text] [Related]
20. Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial.
Gong X; Liu WX; Tang XP; Wang J; Liu J; Huang QC; Liu W; Fang YF; He DY; Liu Y; Gao ML; Wu QJ; Chen S; Li ZB; Wang Y; Xie YM; Zhang JL; Zhou CY; Ma L; Wang XC; Zhang C; Jiang Q
Front Pharmacol; 2021; 12():679588. PubMed ID: 34113254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
